160 related articles for article (PubMed ID: 27490976)
1. PEMBROLIZUMAB ADMINISTRATION ASSOCIATED WITH POSTERIOR UVEITIS.
Aaberg MT; Aaberg TM
Retin Cases Brief Rep; 2017 Fall; 11(4):348-351. PubMed ID: 27490976
[TBL] [Abstract][Full Text] [Related]
2. Vision loss with pembrolizumab treatment: A report of two cases.
Telfah M; Whittaker TJ; C Doolittle G
J Oncol Pharm Pract; 2019 Sep; 25(6):1540-1546. PubMed ID: 30997872
[TBL] [Abstract][Full Text] [Related]
3. Pembrolizumab-related Bilateral Ocular Hypotony, Uveitis, Cataracts, Exudative Retinal, and Choroidal Detachments: An Unusual Success Story.
Golash V; Almeida G
J Immunother; 2020; 43(9):283-285. PubMed ID: 32740318
[TBL] [Abstract][Full Text] [Related]
4. Management of Chronic Hypotony Following Bilateral Uveitis in a Patient Treated with Pembrolizumab for Cutaneous Metastatic Melanoma.
Reid G; Lorigan P; Heimann H; Hovan M
Ocul Immunol Inflamm; 2019; 27(6):1012-1015. PubMed ID: 29672247
[No Abstract] [Full Text] [Related]
5. A Rare Case of Pembrolizumab-Induced Uveitis in a Patient with Metastatic Melanoma.
Hanna KS
Pharmacotherapy; 2016 Nov; 36(11):e183-e188. PubMed ID: 27716999
[TBL] [Abstract][Full Text] [Related]
6. Bilateral ipilimumab-induced posterior uveitis following treatment for metastatic choroidal melanoma.
Tan AX; Ang A; Campbell WG; Fabinyi DC
Clin Exp Ophthalmol; 2018 Sep; 46(7):819-821. PubMed ID: 29653019
[No Abstract] [Full Text] [Related]
7. BILATERAL SEROUS RETINAL DETACHMENT AND UVEITIS ASSOCIATED WITH PEMBROLIZUMAB TREATMENT IN METASTATIC MELANOMA.
de Vries EW; Schauwvlieghe AS; Haanen JB; de Hoog J
Retin Cases Brief Rep; 2022 Jul; 16(4):430-434. PubMed ID: 32243282
[TBL] [Abstract][Full Text] [Related]
8. The use of pembrolizumab for the treatment of metastatic uveal melanoma.
Kottschade LA; McWilliams RR; Markovic SN; Block MS; Villasboas Bisneto J; Pham AQ; Esplin BL; Dronca RS
Melanoma Res; 2016 Jun; 26(3):300-3. PubMed ID: 26848796
[TBL] [Abstract][Full Text] [Related]
9. Case report: Bilateral uveitis and papillitis secondary to treatment with pembrolizumab.
Navarro-Perea C; Garcia-Gonzalez J; Perez-Blazquez E
Indian J Ophthalmol; 2019 Dec; 67(12):2075-2077. PubMed ID: 31755465
[TBL] [Abstract][Full Text] [Related]
10. BILATERAL CHOROIDAL DETACHMENTS SECONDARY TO IPILIMUMAB AND PEMBROLIZUMAB USE.
O'Bryhim BE; Sychev Y; Rao PK
Retin Cases Brief Rep; 2021 May; 15(3):230-233. PubMed ID: 30044269
[TBL] [Abstract][Full Text] [Related]
11. Uveal melanoma in the peripheral choroid masquerading as chronic uveitis.
Feng L; Zhu J; Gao T; Li B; Yang Y
Optom Vis Sci; 2014 Sep; 91(9):e222-5. PubMed ID: 25036546
[TBL] [Abstract][Full Text] [Related]
12. Vitiligo Repigmentation with Melanoma Progression During Pembrolizumab Treatment.
Nardin C; Pelletier F; Puzenat E; Aubin F
Acta Derm Venereol; 2019 Sep; 99(10):913-914. PubMed ID: 31017249
[No Abstract] [Full Text] [Related]
13. Two cases of clinical myasthenia gravis associated with pembrolizumab use in responding melanoma patients.
Nguyen BH; Kuo J; Budiman A; Christie H; Ali S
Melanoma Res; 2017 Apr; 27(2):152-154. PubMed ID: 27776019
[TBL] [Abstract][Full Text] [Related]
14. Granulomatous Tumoral Melanosis Associated With Pembrolizumab Therapy: A Mimicker of Disease Progression in Metastatic Melanoma.
Woodbeck R; Metelitsa AI; Naert KA
Am J Dermatopathol; 2018 Jul; 40(7):523-526. PubMed ID: 29924748
[TBL] [Abstract][Full Text] [Related]
15. Motor polyradiculopathy during pembrolizumab treatment of metastatic melanoma.
Sepúlveda M; Martinez-Hernandez E; Gaba L; Victoria I; Sola-Valls N; Falgàs N; Casanova-Molla J; Graus F
Muscle Nerve; 2017 Dec; 56(6):E162-E167. PubMed ID: 28439919
[TBL] [Abstract][Full Text] [Related]
16. Generalized morphea in the setting of pembrolizumab.
Cheng MW; Hisaw LD; Bernet L
Int J Dermatol; 2019 Jun; 58(6):736-738. PubMed ID: 29931792
[No Abstract] [Full Text] [Related]
17. A case of bilateral uveitis and papillitis in a patient treated with pembrolizumab.
Abu Samra K; Valdes-Navarro M; Lee S; Swan R; Foster CS; Anesi SD
Eur J Ophthalmol; 2016 Apr; 26(3):e46-8. PubMed ID: 26692064
[TBL] [Abstract][Full Text] [Related]
18. Lichen planus in a patient treated with pembrolizumab for metastatic malignant melanoma.
Denny J; Chong H; Akhras V
Clin Exp Dermatol; 2018 Apr; 43(3):354-356. PubMed ID: 29222829
[No Abstract] [Full Text] [Related]
19. Pembrolizumab-Induced Pancytopenia: A Case Report.
Atwal D; Joshi KP; Ravilla R; Mahmoud F
Perm J; 2017; 21():17-004. PubMed ID: 28746020
[TBL] [Abstract][Full Text] [Related]
20. In vivo Confocal Microscopy in Differentiating Ipilimumab-Induced Anterior Uveitis from Metastatic Uveal Melanoma.
Kiratli H; Mocan MC; İrkeç M
Case Rep Ophthalmol; 2016; 7(3):126-131. PubMed ID: 27790127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
